Herbas VPB

Print
EN | LT
LT - Telomerazės inhibitoriaus ir gemcitabino derinys, skirtas vėžio gydymui
EN - COMBINED TELOMERASE INHIBITOR AND GEMCITABINE FOR THE TREATMENT OF CANCER

Legal status

Patent in force

Claims | Licences
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/70 (2006.01)
European patent
(11) Number of the document 2101789
(13) Kind of document T
(96) European patent application number 07867297.9
Date of filing the European patent application 2007-10-30
(97) Date of publication of the European application 2009-09-23
(45) Date of publication and mention of the grant of the patent 2014-12-31
(46) Date of publication of the claims translation 2015-04-27
PCT application
(86) Number PCT/US2007/022850
Date 2007-10-30
PCT application publication
(87) Number WO 2008/054711
Date 2008-05-08
Priority applications
(30) Number Date Country code
855583 P 2006-10-30 US
Inventors
(72)
GO, Ning, US
TRESSLER, Robert J., US
Grantee
(73) Geron Corporation, 149 Commonwealth Drive, Menlo Park, CA 94025, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Telomerazės inhibitoriaus ir gemcitabino derinys, skirtas vėžio gydymui
  COMBINED TELOMERASE INHIBITOR AND GEMCITABINE FOR THE TREATMENT OF CANCER
Last renewal fee
Payment date Validity (years) Amount
2024-09-23 18 347.00 EUR
Next renewal fee
2025-10-30
Last update date 2024-09-25